Suicide in China: The Trends and Differentials From 2002 to 2021

被引:1
|
作者
Hu, Fei-Hong [1 ]
Liu, Peng [1 ]
Jia, Yi-Jie [1 ]
Ge, Meng-Wei [1 ]
Shen, Lu-Ting [1 ]
Xia, Xiao-Peng [2 ]
Chen, Hong-Lin [1 ]
机构
[1] Nantong Univ, Sch Nursing & Rehabil, Nantong, Jiangsu, Peoples R China
[2] Tradit Chinese Med Hosp Nantong City, Dept Orthopaed, Nantong, Jiangsu, Peoples R China
关键词
China; suicide; suicide differential; suicide trend; RATES;
D O I
10.1002/cpp.3053
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The objective of this study was to provide an updated analysis of suicide characteristics in China from 2002 to 2021, with the aim of informing the development of evidence- based suicide prevention strategies. Methods: The Ministry of Health- Vital Registration System (MOH- VR) provided the data on suicide mortality, which enabled us to examine the average annual percentage change (AAPC) in suicide rates using a Poisson regression model. Results: Notably, there has been a significant decline in suicide rates observed in both urban and rural areas. In the early years of the study period, higher suicide rates were observed among females compared to males; however, a shift occurred after 2005, with male suicide rates surpassing those of females. Except for 2005, rural areas consistently exhibited higher suicide rates than urban areas. Furthermore, suicide rates exhibited an increasing trend with age, irrespective of gender or region. Conclusion: These findings highlight a decreasing trend in suicide rates in China over the past two decades, although gender and regional disparities persist. Going forward, sustained efforts in suicide prevention, with a specific focus on mental health, are warranted.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Trends and gender differentials in age-specific suicide mortality, 2004-2020, Cyprus
    Middleton, N.
    Karanikola, M.
    Chatzittofis, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [42] Analysis of taiga and tundra lake browning trends from 2002 to 2021 using MODIS data
    Wang, Zijin
    Shang, Yingxin
    Li, Zuchuan
    Song, Kaishan
    JOURNAL OF ENVIRONMENTAL MANAGEMENT, 2024, 356
  • [43] Research trends in the field of retinitis pigmentosa from 2002 to 2021: a 20 years bibliometric analysis
    Lin, Feng
    Xie, Minyue
    Sheng, Xiaonan
    Guo, Lingxi
    Jia, Jinchao
    Wang, Yimin
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (06) : 1825 - 1833
  • [44] Research trends in the field of retinitis pigmentosa from 2002 to 2021: a 20 years bibliometric analysis
    Feng Lin
    Minyue Xie
    Xiaonan Sheng
    Lingxi Guo
    Jinchao Jia
    Yimin Wang
    International Ophthalmology, 2023, 43 : 1825 - 1833
  • [45] CHINA DIFFERENTIALS
    不详
    ECONOMIST, 1957, 183 (11): : 977 - 978
  • [46] Analysis of terrestrial water storage and its component changes in china from 2002 to 2021
    Chu J.
    Su X.
    Wu H.
    Liu Y.
    Feng K.
    Water Resources Protection, 2023, 39 (03) : 170 - 178
  • [47] Progress and challenges in integrated traditional Chinese and western medicine in China from 2002 to 2021
    Zhou, Man-Ci
    Fei, Yu-Tong
    Lai, Xiao-Zhen
    Lan, Jian
    Liu, Bo
    Wang, Zhi-Wei
    Fang, Hai
    Liu, Jian-Ping
    Rong, Hong-Guo
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [48] Trends in black-white differentials in dietary intakes of US adults, 1971-2002
    Kant, Ashima K.
    Graubard, Barry I.
    Kumanyika, Shiriki K.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2007, 32 (04) : 264 - 272
  • [49] The burden of multiple myeloma in China: Trends from 1990 to 2021 and forecasts for 2050
    Dou, Xuelin
    Duan, Guixiang
    Zhong, Yanting
    Liu, Yang
    Peng, Nan
    Wen, Lei
    Qi, Jinlei
    Zhou, Maigeng
    Zhang, Xiaohui
    Lu, Jin
    CANCER LETTERS, 2025, 611
  • [50] Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
    Hao, Jun
    Li, Chen
    Li, Junrong
    Wang, Chuangshi
    Li, Yang
    He, Chen
    Liu, Weida
    Li, Sidong
    Zuo, Ling
    Hui, Wen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (03) : 301 - 310